Compare SUPN & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUPN | LION |
|---|---|---|
| Founded | 2005 | 1997 |
| Country | United States | United States |
| Employees | N/A | 1032 |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | 2012 | N/A |
| Metric | SUPN | LION |
|---|---|---|
| Price | $51.53 | $8.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 10 |
| Target Price | ★ $61.60 | $9.11 |
| AVG Volume (30 Days) | 690.1K | ★ 2.5M |
| Earning Date | 11-04-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $681,539,000.00 | ★ $3,858,000,000.00 |
| Revenue This Year | $8.32 | N/A |
| Revenue Next Year | $23.36 | $22.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 4.54 | ★ 21.18 |
| 52 Week Low | $29.16 | $5.55 |
| 52 Week High | $57.65 | $9.24 |
| Indicator | SUPN | LION |
|---|---|---|
| Relative Strength Index (RSI) | 68.51 | 67.21 |
| Support Level | $45.36 | $7.55 |
| Resistance Level | $47.26 | $8.75 |
| Average True Range (ATR) | 1.47 | 0.40 |
| MACD | 0.70 | 0.07 |
| Stochastic Oscillator | 92.77 | 71.80 |
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.